11C-MET PET
11C-methionine PET
MRI
pediatric high-grade glioma
pseudoprogression
recurrence
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
received:
05
01
2021
revised:
11
08
2021
pubmed:
28
8
2021
medline:
4
5
2022
entrez:
27
8
2021
Statut:
ppublish
Résumé
Differentiating tumor recurrence or progression from pseudoprogression during surveillance of pediatric high-grade gliomas (PHGGs) using MRI, the primary imaging modality for evaluation of brain tumors, can be challenging. The aim of this study was to evaluate whether
Identifiants
pubmed: 34446453
pii: jnumed.120.261891
doi: 10.2967/jnumed.120.261891
pmc: PMC9051591
doi:
Substances chimiques
Methionine
AE28F7PNPL
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
664-671Subventions
Organisme : NCI NIH HHS
ID : P30 CA021765
Pays : United States
Organisme : NCI NIH HHS
ID : R25 CA023944
Pays : United States
Informations de copyright
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.
Références
Cancer. 2010 Feb 1;116(3):705-12
pubmed: 19957326
J Neurooncol. 2015 Oct;125(1):167-75
pubmed: 26384811
Eur J Nucl Med Mol Imaging. 2015 Apr;42(5):685-95
pubmed: 25411133
Radiology. 2014 Apr;271(1):200-10
pubmed: 24475840
Lancet Oncol. 2018 Dec;19(12):1561-1563
pubmed: 30507413
J Neurooncol. 2017 Mar;132(1):163-170
pubmed: 28078638
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):540-557
pubmed: 30519867
Comput Methods Programs Biomed. 1991 Jun;35(2):141-50
pubmed: 1914452
J Neurooncol. 2016 Aug;129(1):109-21
pubmed: 27180091
J Clin Neurosci. 2018 Dec;58:130-135
pubmed: 30243602
Nucl Med Biol. 2012 Oct;39(7):977-81
pubmed: 22483845
Sci Rep. 2019 Oct 30;9(1):15666
pubmed: 31666650
Neuro Oncol. 2012 Jul;14(7):919-30
pubmed: 22561797
J Clin Oncol. 2015 Sep 20;33(27):2986-98
pubmed: 26304884
J Neurooncol. 2017 Sep;134(3):495-504
pubmed: 28382534
Lancet Oncol. 2008 May;9(5):453-61
pubmed: 18452856
PLoS One. 2015 Jul 13;10(7):e0132515
pubmed: 26167681
J Nucl Med. 2020 Apr;61(4):505-511
pubmed: 31519802
Radiology. 2013 Dec;269(3):831-40
pubmed: 23771912
Neuro Oncol. 2019 Sep 6;21(9):1118-1130
pubmed: 30828724
Nat Rev Clin Oncol. 2017 Jul;14(7):434-452
pubmed: 28031556
Neuro Oncol. 2014 Apr;16(4):603-9
pubmed: 24305722
Neuro Oncol. 2014 Dec;16(12):1652-60
pubmed: 24908655
Neuro Oncol. 2016 Sep;18(9):1199-208
pubmed: 27106405
Lancet Neurol. 2010 Sep;9(9):906-20
pubmed: 20705518
J Neurooncol. 2010 Sep;99(2):217-25
pubmed: 20091333
Nat Commun. 2019 Jul 18;10(1):3170
pubmed: 31320621
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1049-58
pubmed: 21570201
Clin Nucl Med. 2011 Nov;36(11):978-81
pubmed: 21975383
J Nucl Med. 2008 May;49(5):694-9
pubmed: 18413375
AJNR Am J Neuroradiol. 2013 May;34(5):944-50, S1-11
pubmed: 23124638
Rev Esp Med Nucl Imagen Mol. 2017 Mar - Apr;36(2):85-90
pubmed: 27503425
J Neurooncol. 2018 Mar;137(1):103-110
pubmed: 29204840
Neurol Med Chir (Tokyo). 2014;54(4):280-9
pubmed: 24305028
Cancer. 2013 Oct 1;119(19):3479-88
pubmed: 23821555
Clin Neurol Neurosurg. 2010 Nov;112(9):758-65
pubmed: 20619531
Clin Nucl Med. 2016 May;41(5):e228-36
pubmed: 26859208
Nat Rev Neurol. 2017 May;13(5):279-289
pubmed: 28387340
Neuro Oncol. 2015 Sep;17(9):1293-300
pubmed: 26008606
Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1458-1467
pubmed: 31919633
Front Oncol. 2012 Aug 24;2:105
pubmed: 22937526
Neuro Oncol. 2020 Jan 11;22(1):116-127
pubmed: 31419298
J Nucl Med. 2015 Jan;56(1):88-92
pubmed: 25525183
Neuro Oncol. 2021 Dec 1;23(12):2107-2116
pubmed: 33864083
J Clin Oncol. 2010 Apr 10;28(11):1963-72
pubmed: 20231676
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
J Neurosurg Pediatr. 2010 May;5(5):486-99
pubmed: 20433263
Clin Cancer Res. 2016 May 1;22(9):2190-6
pubmed: 26673798